News & Events

Welcome to Dalton Pharma Services News and Events.

On this page you will find our current and past news releases and a list of event happenings. If you can't find what you are looking for, please contact us and we will be happy to provide you with assistance.

1/17/2017 09:00 Dalton Announces Drug Development and Manufacturing Services Agreement with Cerium Pharmaceuticals

Dalton Pharma Services today announced the signing of a drug development and manufacturing services agreement with Cerium Pharmaceuticals, Inc., an emerging biopharmaceutical company based in Gaithersburg, Maryland, USA.

12/20/2016 09:00 Dalton Enters Into Agreement With the USAMMDA in Support of the US Army’s Drug Development Program

Dalton entered into an Agreement with the US Army Medical Materiel Development Activity (USAMMDA) and will provide cGMP sterile powder filling, aseptic liquid filling, and ICH stability testing in support of the US Army’s anti-malarial drug development program.

11/22/2016 09:00 Dalton Pharma Services officially certified as a Great Place to Work

Dalton Pharma Services officially certified as a Great Place to Work following independently-conducted employee surveys

8/30/2016 18:25 Dalton Announces Completion of a Major Expansion in Sterile Filling and API Manufacturing

Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical and biotechnology companies, announced today the completion of a $5 million expansion in sterile filling and API manufacturing at its cGMP facility in Toronto, Canada.

6/29/2016 09:00 Dalton Announces Addition of Flow Chemistry Technology

Dalton Pharma Services announced today the addition of Flow Chemistry Reactor Technology to the services offered to its clients. This exciting new technology is now part of Dalton’s extensive arsenal of capabilities in the area of custom synthesis and process development and has many benefits including increased scalability, flexibility, and process control.

6/7/2016 13:12 Averica & Dalton Announce Analytical Chemistry Services Agreement

Averica Discovery Services Inc., an analytical development Contract Research Organization (CRO) based in the Greater Boston area, and Dalton Pharma Services, a contract provider of integrated chemistry, drug development, and manufacturing services located in Toronto, today announce a preferred provider agreement involving advanced analytical services.

2/17/2016 10:08 Dalton on FDA List of Registered Facilities for 2016
Dalton Pharma Services is now on the FDA list of registered facilities as an API manufacturing, testing and packaging facility for 2016.
2/3/2016 10:38 2016 CMO Leadership Award Won by Dalton Pharma Services

Dalton Pharma Services, a leading pharmaceutical cGMP contract manufacturing company, announced today that it has been selected by its clients to receive a 2016 CMO Leadership Award in all five core categories in the competition: Quality, Reliability, Capabilities, Expertise and Compatibility.

8/11/2015 20:00 Dalton Pharma Services Rated Compliant with New Health Canada API Regulations

Dalton Pharma Services today announced that a recent Health Canada inspection of its API manufacturing operations resulted in a “Compliant” rating against the newest Health Canada API manufacturing guidance.

7/7/2015 20:00 Dalton Pharma Services Announces Manufacturing and Development Agreement with Ramsey Lake Pharma

Dalton Pharma Services announces Agreement with Ramsey Lake Pharma for the synthesis and testing of VR23 to support their upcoming toxicology studies for their VR23 oncology candidate drug.